Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer

NCT00375310 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Adenocarcinoma of the Pancreas

Interventions

DRUG: Gemcitabine, Sorafenib
PROCEDURE: Radiotherapy

Sponsor

Indiana University

Collaborators

[object Object]